Short answer
Monopar Therapeutics (MNPR) filed an 8-K current report with the SEC on June 23, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Annual meeting represented 5,760,392 of 6,698,778 eligible shares, indicating approximately 86% participation.
Monopar Therapeutics 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Annual meeting represented 5,760,392 of 6,698,778 eligible shares, indicating approximately 86% participation
- All six director nominees elected, with For votes ranging from 4,203,485 to 4,911,758
- Executive compensation approved on advisory basis, with 4,355,628 For votes
- 2026 Stock Incentive Plan approved, authorizing the company’s equity-compensation framework
- BPM LLP ratified as independent auditor for 2026, with 5,759,198 For votes and 998 Against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Monopar Therapeutics 8-K filings
Get the next MNPR 8-K as it lands
Follow MNPR for push alerts, or ask the research agent what this filing means.